Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

University of California, Davis39 enrolled

Overview

This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Type 1 Diabetes

Interventions

Remote Patient MonitoringBEHAVIORAL

Participants' glucose data will be monitored by the study team using population analytic reports. Participants who either have excessive hypoglycemia or hyperglycemia on these reports will be contacted by a pediatric endocrinologist (the principal investigator) to discuss any necessary adjustments to their home diabetes management plans. This intervention will be in addition to their usual care (regular visits at the UC Davis Pediatric Endocrinology clinic).

Eligibility

Sex: ALLMin age: 1 YearMax age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnoses of type 1 diabetes with a duration of greater than or equal to 12 months * Use of a continuous glucose monitor (CGM) for greater than or equal to 6 months * Intention to continue receiving care at the UC Davis Health Pediatric Diabetes clinic. Exclusion Criteria: * Patient's CGM cannot be uploaded to Glooko

Locations (1)

University of California-Davis

Sacramento, California, United States

Outcomes

Primary Outcomes

Feasibility of remote glucose monitoring for pediatric T1D patients who receive care at UC Davis Health

Proportion of participants who have successfully established remote glucose monitoring by the end of the baseline period.

Time frame: 1 month baseline period

Change in hemoglobin A1c (HbA1c)

HbA1c at study completion minus the HbA1c at initiation

Time frame: Initiation = 1 month after enrollment, Study completion = 7 months after enrollment

Secondary Outcomes

Data-sharing experience survey

Survey asking about patient's experience with data-sharing

Time frame: 1 month after enrollment

Target Glucose Range

Percentage of time spent in target glucose range (generated from continuous glucose monitor)

Time frame: Months 1-7 after enrollment

Hyperglycemic range

Percentage of time spent in hyperglycemic range (generated from continuous glucose monitor)

Time frame: Months 1-7 after enrollment

Hypoglycemic range

Percentage of time spent in hypoglycemic range (generated from continuous glucose monitor)

Time frame: Months 1-7 after enrollment

Overall continuous glucose monitor (CGM) wear time

Percentage of time spent wearing continuous glucose monitor (generated from continuous glucose monitor)

Time frame: Months 1-7 after enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.